Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Steven Weeden

Adult Reconstructive Orthopaedic Surgery Fort Worth, TX Medical Doctor

NPI 1952342040 CMS profile 179723

6301 Harris Pkwy Ste 300, Fort Worth, TX 76132

Open in the dashboard

General payments

$370,257

70 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Steven Weeden of Fort Worth, TX is reported in the CMS Open Payments database as having received $370,257 across 70 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 91st percentile of Adult Reconstructive Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $13,711 4
2024 General $48,753 6
2023 General $80,794 8
2022 General $73,453 8
2021 General $53,011 7
2020 General $60,400 17
2019 General $40,135 20

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Steven Weeden
  • Adult Reconstructive Orthopaedic Surgery median
  • Middle half of Adult Reconstructive Orthopaedic Surgery
  • National median

In program year 2025, general payments to Steven Weeden were reported at $13,711. Among 1,079 Adult Reconstructive Orthopaedic Surgery profiles paid that year, the median was $1,406 and the middle half received between $318 and $8,709.

Show as a table
Year Steven Weeden Adult Reconstructive Orthopaedic Surgery median Middle half National median
2019 $40,135 $1,416 $292–$9,336 $163
2020 $60,400 $647 $141–$6,474 $114
2021 $53,011 $1,073 $211–$6,497 $132
2022 $73,453 $1,217 $236–$6,299 $149
2023 $80,794 $1,082 $246–$6,818 $160
2024 $48,753 $1,575 $323–$8,944 $164
2025 $13,711 $1,406 $318–$8,709 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Smith+Nephew, Inc. $370,120 63 payments
  2. Stryker Corporation $38 1 payment
  3. Abbott Laboratories $25 1 payment
  4. Heraeus Medical, LLC. $23 1 payment
  5. Baxter Healthcare $20 1 payment
  6. Ethicon US, LLC $17 1 payment
  7. Radius Health, Inc. $12 1 payment
  8. Fidia Pharma USA Inc. $1 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $307,199 34 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $58,930 8 payments
  3. Travel and Lodging $2,758 10 payments
  4. Food and Beverage $909 17 payments
  5. Consulting Fee $460 1 payment
Products named General payments · program years 2019–2025
  1. LEGION Recon Knees $165,440 17 payments
  2. REDAPT Recon Hips $59,088 8 payments
  3. LEGION TKS Recon Knees $44,993 5 payments
  4. Legion Revision $40,363 13 payments
  5. Legion Hinge $38,886 7 payments
  6. LEGION TKS Recon Knees $37,679 4 payments
  7. Legion Recon Knees $24,265 2 payments
  8. Journey II XR $13,481 7 payments
  9. JII Unicondylar Knee System $12,535 1 payment
  10. REDAPT Recon Hips $11,915 5 payments
  11. Other $45,625 30 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 18 billing codes

Paid by Medicare

$29,080

Medicare's payments for the services billed

Medicare patients

94

Average age 74

Services billed

419

50 women, 44 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 32%
Chronic kidney disease 22%
Diabetes 21%
Atrial fibrillation 20%
Depression 19%
Cancer 15%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

70 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Adult Reconstructive Orthopaedic Surgery in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record